These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2342577)

  • 1. Presentation of viral antigen controlled by a gene in the major histocompatibility complex.
    Cerundolo V; Alexander J; Anderson K; Lamb C; Cresswell P; McMichael A; Gotch F; Townsend A
    Nature; 1990 May; 345(6274):449-52. PubMed ID: 2342577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential recruitment of viral and allo-epitopes into the MHC class I antigen processing pathway of a novel mutant of Ltk- cells. HSV/MHC class I restriction/immune recognition/antigen processing/antigen presentation/influenza virus.
    Lippé R; Kolaitis G; Michaelis C; Tufaro F; Jefferies WA
    J Immunol; 1993 Apr; 150(8 Pt 1):3170-9. PubMed ID: 7682234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A defect in the presentation of intracellular viral antigens is restored by interferon-gamma in cell lines with impaired major histocompatibility complex class I assembly.
    Sibille C; Gould K; Hämmerling G; Townsend A
    Eur J Immunol; 1992 Feb; 22(2):433-40. PubMed ID: 1537379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Class II MHC molecules can use the endogenous pathway of antigen presentation.
    Nuchtern JG; Biddison WE; Klausner RD
    Nature; 1990 Jan; 343(6253):74-6. PubMed ID: 1967486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen presentation and the association of class-I molecules.
    Elliott TJ; Cerundolo V; Ohlen C; Ljunggren HG; Karre K; Townsend A
    Acta Biol Hung; 1991; 42(1-3):213-29. PubMed ID: 1726936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer.
    Spies T; Cerundolo V; Colonna M; Cresswell P; Townsend A; DeMars R
    Nature; 1992 Feb; 355(6361):644-6. PubMed ID: 1538752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen.
    Pinet V; Malnati MS; Long EO
    J Immunol; 1994 May; 152(10):4852-60. PubMed ID: 8176208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three different MHC class I molecules bind the same CTL epitope of the influenza virus in a primate species with limited MHC class I diversity.
    Evans DT; Knapp LA; Jing P; Piekarczyk MS; Hinshaw VS; Watkins DI
    J Immunol; 1999 Apr; 162(7):3970-7. PubMed ID: 10201917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of labelled influenza matrix peptide to HLA DR in living B lymphoid cells.
    Ceppellini R; Frumento G; Ferrara GB; Tosi R; Chersi A; Pernis B
    Nature; 1989 Jun; 339(6223):392-4. PubMed ID: 2786148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules.
    Morris P; Shaman J; Attaya M; Amaya M; Goodman S; Bergman C; Monaco JJ; Mellins E
    Nature; 1994 Apr; 368(6471):551-4. PubMed ID: 8139689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MHC-encoded proteasome subunits LMP2 and LMP7 are not required for efficient antigen presentation.
    Yewdell J; Lapham C; Bacik I; Spies T; Bennink J
    J Immunol; 1994 Feb; 152(3):1163-70. PubMed ID: 8301122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of overlapping class I and class II H-2d-restricted T cell determinants of influenza virus N1 neuraminidase that require infectious virus for presentation.
    Wysocka M; Eisenlohr LC; Otvos L; Horowitz D; Yewdell JW; Bennink JR; Hackett CJ
    Virology; 1994 May; 201(1):86-94. PubMed ID: 7513927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2.
    Gotch F; Rothbard J; Howland K; Townsend A; McMichael A
    Nature; 1987 Apr 30-May 6; 326(6116):881-2. PubMed ID: 2437457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An endogenous antigenic peptide bypasses the class I antigen presentation defect in RMA-S.
    Hosken NA; Bevan MJ
    J Exp Med; 1992 Mar; 175(3):719-29. PubMed ID: 1311017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of antigen presentation of influenza A nucleoprotein expressed in attenuated AroA- Salmonella typhimurium with that of live virus.
    Brett SJ; Rhodes J; Liew FY; Tite JP
    J Immunol; 1993 Apr; 150(7):2869-84. PubMed ID: 7681081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular transport of class I MHC molecules in antigen processing mutant cell lines.
    Anderson KS; Alexander J; Wei M; Cresswell P
    J Immunol; 1993 Oct; 151(7):3407-19. PubMed ID: 8376783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs.
    Albert ML; Sauter B; Bhardwaj N
    Nature; 1998 Mar; 392(6671):86-9. PubMed ID: 9510252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen.
    Sigal LJ; Crotty S; Andino R; Rock KL
    Nature; 1999 Mar; 398(6722):77-80. PubMed ID: 10078533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-presentation in viral immunity and self-tolerance.
    Heath WR; Carbone FR
    Nat Rev Immunol; 2001 Nov; 1(2):126-34. PubMed ID: 11905820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.